The Safety System Around the Model: Data, People, and Power

Language-specific medical AI testing is only as meaningful as the people, voices, and workflows represented in the system around the model. This chapter traces that wider safety lifecycle: how speech and clinical data shape what can be tested, how communities and institutions influence data access and accountability, and how cost, maintenance, staffing, and workforce effects can determine whether safeguards survive deployment. The practical judgment is that a strong multilingual benchmark is necessary but not sufficient; the surrounding system must be able to support review, remediation, and participation.

A language benchmark begins with the voices it can represent

A benchmark does not start when a model produces an answer. It starts earlier, in the data and speech conditions that determine what the model has encountered and what evaluators can measure. This matters especially for clinical speech systems. A language label can hide regional accents, dialects, age-related changes, gender diversity, speech impairments, and the difference between carefully read sentences and real clinical conversation.

The speech-focused review examined 38 publicly available automatic speech recognition and text-to-speech datasets published between 2015 and 2024. It assessed language coverage, accent diversity, demographic representation, and inclusion of speech impairments. The review found a strong English concentration, uneven metadata, limited coverage of nonstandard accents, and very little explicit representation of gender-diverse speakers or detailed age and ethnicity. It did not identify native African or Indigenous languages in the datasets it reviewed, and it did not identify a dataset explicitly containing impaired speech samples in that search.

Those findings do not establish that no such datasets exist. The review depended on PapersWithCode and on the information dataset creators made available. Proprietary, less visible, or differently indexed resources may not appear. “Not identified in this review” is therefore the correct boundary, not “does not exist.” The value of the result is diagnostic: it shows how easily a language benchmark can be interpreted without knowing whether the relevant voices, accents, or impairments were present upstream.

The same issue affects clinical interpretation. If a speech-to-text system has learned mostly standardized accents, a low error rate on those voices says little about a patient whose accent or speech impairment was not represented. If a transcription is accurate for a read sentence but loses a dialectal expression in a consultation, the clinical record may change even though the language is nominally supported. If an older adult’s speech pattern is underrepresented, a system may omit symptoms or medication details in the very population that depends heavily on clear documentation. These are possible pathways of risk, not effects measured by the review; they explain why representation belongs in the safety question.

The review’s research-trend analysis points to a related problem of attention. Its control search rose from 21 health speech-AI papers in 2015 to 676 in 2024.